Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index; none of the 82 sources its claims cite is checked for support yet.

Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease

Open access

Overview

CoChat Summary

TL;DR

In human hippocampal tissue, GFAP isoform transcripts are differentially abundant and most increase with Alzheimer’s disease progression, while GFAPd and GFAP+1 define distinct astrocyte populations. GFAP+1 cells are a non-reactive astrocyte subset whose numbers rise with amyloid/Braak stage and can be induced by Aβ1-42 in vitro.

Key findings

  • Ten GFAP transcripts were detected. With GFAPa set at 100% in amyloid O donors, median relative levels were GFAPd 1.5%, GFAPk 1.1%, GFAPz 0.21%, GFAPD135 0.24%, GFAPb 0.00120%, GFAPDEx6 0.009%, GFAPDEx7 0.006%, and GFAPD164 0.00017%; GFAPDEx6 was detected in 56/75 samples and GFAPD164 in 49/75.
  • Most GFAP isoform transcripts increased with AD progression: GFAPa rose 1.3-fold in amyloid A, 2.1-fold in amyloid B, and 2.5-fold in amyloid C versus amyloid O, and increased about 2-fold at Braak 1–3 and about 3-fold at Braak 4–6. GFAPb decreased at Braak stages 3 and 4, with an 8-fold reduction at Braak 3 versus Braak 0 (0.00015% vs. 0.00120%).
  • GFAPd immunostaining was prominent in subgranular zone, hilus, CA4, and stratum lacunosum-moleculare, co-localized with GFAPc-term/GFAPa, and was increased in reactive astrocytes near plaques in CA1–3 and subiculum. GFAPk protein could not be detected.
  • GFAP+1 cells/cm² ranged from 4 to 82 and correlated with amyloid stage (Rs = 0.58, p < 0.001) and Braak stage (Rs = 0.59, p < 0.001), as well as plaque number density (Rs = 0.62, p < 0.001) and plaque coverage (Rs = 0.47, p < 0.001). In amyloid O–A donors, age added 0.23 GFAP+1 cells/cm² per year (Rs = 0.53, p = 0.017), and females had more GFAP+1 cells/cm² than males (32.4 ± 0.2 vs. 22.0 ± 0.2, p = 0.007). Aβ1-42 oligomers/fibrils induced GFAP+1-positive cells in U343 astrocytoma cultures.

Methods

  • Post-mortem human hippocampal tissue was obtained from the Netherlands Brain Bank: 75 donors ranked by amyloid score (O, A, B, C) and Braak staged for tau, plus 10 donors without an NBB amyloid score but with tau scoring. RNA with RIN < 5.0 was excluded; qPCR for GFAP isoforms used a normalization factor based on 10 reference genes.
  • Immunofluorescence was performed on lightly fixed cryosections with isoform-specific antibodies; Western blotting used recombinant GFAP isoforms expressed in SW-13cl.2 cells. Cell culture experiments used U343 astrocytoma and SW-13cl.2 cells, including Aβ1-42 oligomer/fibril treatment and MTT assays.
  • GFAP+1 cells and amyloid plaques were quantified in hippocampal sections, and analyses used non-parametric methods (Kruskal-Wallis, Spearman rank correlation, Mann-Whitney U), with p < 0.05 considered significant.

Limitations

  • Stated in the paper: the qPCR isoform profile is based on plasmid calibration curves and does not correct for potential different cDNA synthesis efficiencies among transcripts; GFAP+1-encoding transcripts are very low, variable, and not detectable in all samples, and it is unknown whether they originate only from GFAP+1 cells or from all astrocytes at very low abundance.
  • Stated in the paper: overexpression constructs express the N-terminus of GFAPa, but the exact in vivo N-terminal head domain of GFAPD164 and GFAPDEx6 has not been determined, so the constructs may not represent endogenous GFAP+1 isoforms and filament-formation results may differ. The paper also notes it could not determine which transcript underlies GFAP+1 protein in vivo, and laser dissection of GFAP+1 cells did not yield a consistent transcript profile.
  • Evident from the text: this is a human post-mortem correlational study; amyloid O donors were significantly younger than amyloid B and C donors, and age and sex effects on GFAP+1 cell numbers were observed, so AD-related increases may be partly confounded by age/sex. The paper states that whether the increase in GFAP+1 cells has consequences for the disease process cannot be derived from the data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2013.09.035

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 45 Not checked · 210 Own results and interpretations

125 more claims

Create a free account to see all 255 claims and to verify the 75 references still open.

See all claims — free account
  • It may state two separate claims as one. 99
  • The quote only partly states this claim. 4
  • Probably not a substantial claim. 44

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 75 references

Cited by

See all 271

Metadata

Authors
Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E.-J., Moeton, M., Freriks, M., Mizee, M. R., & Hol, E. M.
Affiliations
Netherlands Institute for Neuroscience (NL)
Corresponding author
Kamphuis, Willem
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2014-03
Volume
35
Issue
3
Pages
492-510
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2039930606
Cited by
269
References
75
Citations by year
2026: 17 · 2025: 21 · 2024: 25 · 2023: 24 · 2022: 35 · 2021: 28 · 2020: 27 · 2019: 13 · 2018: 17 · 2017: 23 · 2016: 10 · 2015: 20 · 2014: 9
FWCI
4.40
Type
journal article
Language
en
Open access
Licence
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • Internationale Stichting Alzheimer Onderzoek (ISAO 08504)
  • NANONET COST (BM1002)
  • Netherlands Organization (865.09.003)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
Keywords
Alzheimer's disease, glial fibrillary acidic protein, astrocyte activation, amyloid plaques, reactive astrocytes, intermediate filaments, hippocampus, disease progression, mRNA levels
MeSH terms
Alzheimer Disease, Astrocytes, Cells, Cultured, Glial Fibrillary Acidic Protein, Hippocampus, Humans, Severity of Illness Index, Transcription, Genetic, Up-Regulation, Gene Expression, Disease Progression, Protein Isoforms, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2013.09.035
The paper
Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E.-J., Moeton, M., Freriks, M., Mizee, M. R., & Hol, E. M. (2014). Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2013.09.035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.